BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2026.
World J Transplant. Mar 18, 2026; 16(1): 110628
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.110628
Table 6 Predictors of pulmonary hypertension, n (%)/mean ± SD
VariablesUnivariate analysis
Multivariate analysis
PH
No PH
P value
OR (95%CI)
P value
Age0.23
18-50 years34 (23)115 (77)
> 50 years32 (29)77 (71)
Gender
Male44 (28)114 (72)0.29
Female22 (22)78 (78)
Obesity12 (13)88 (87)0.0010.29 (0.05-1.69)0.17
BMI ranges0.03
< 2540 (33)82 (67)
25-3017 (22)59 (78)0.79 (0.22-2.79)0.71
> 309 (15)51 (75)0.85 (0.10- 7.55)0.88
DD21 (30) 50 (70) 0.37
LVSD9 (29)22 (71)0.65
LVH34 (37)58 (63) 0.02 3.3 (1.05-10.55)0.04
MR (grade 2-3)45 (36)81 (64) < 0.001 4.6 (1.45-14.78)0.01
TR51 (31)115 (69) 0.01 3.70 (0.93-14.69) 0.06
AR18 (40) 27 (60) 0.020.57 (0.16-2.00)0.38
Hypertension64 (25) 187 (75)0.99
Pericardial effusion17 (41)224 (59)0.0122.28 (0.63-8.31)0.21
Dyslipidemia31(32)65 (68)0.0572.80 (0.80-9.81)0.11
Smoking29 (24)92 (76)0.58
Diabetes4 (12)30 (88)0.0480.79 (0.16-9.32)0.77
Impaired fasting glucose32 (25)98 (75)0.72
Hyperuricemia20 (26)57 (74) 0.93
Duration of renal replacement therapy20.29 ± 21.6623.61 ± 22.010.30
Total cholesterol (mmol/L)4.27 ± 1.11 4.45 ± 1.170.28
LDL-cholesterol (mmol/L)2.45 ± 0.932.77 ± 2.280.28
HDL-cholesterol (mmol/L)1.35 ± 0.611.20 ± 0.440.08
Triglyceride (mmol/L) 1.46±0.951.66 ± 1.200.22
Mean phosphate level (mmol/L)1.40 ± 0.461.59 ± 0.600.110.42 (0.18-1.08)0.07
Family history of coronary artery disease2 (10)18 (90)0.100.55 (0.08-3.64)0.54
Pre-emptive transplant1 (7)13 (93) 0.26
Hemodialysis55 (27)152 (73)
Peritoneal dialysis10(28) 26 (72)


Write to the Help Desk